Federal Circuit Clarifies Requirement for Reference to Qualify as 'By Another' Under Pre-AIA Sections 102(a) and (e)

November 3, 2025

Reading Time : 2 min

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

This appeal stemmed from two inter partes review proceedings (IPR) in which Hopewell Pharma Ventures challenged Merck Serono’s (Serono) patents, arguing that the prior art references disclosed the claimed dosing regimens. Serono argued that one of the asserted references did not qualify as prior art under pre-AIA Sections 102(a) and (e) because its relevant disclosure, a 6-line dosing regimen, was not “by another” as required by the statute. The PTAB rejected Serono’s defense and found all challenged claims unpatentable.

On appeal, the Federal Circuit considered the question of “whether and to what extent a disclosure invented by fewer than all named inventors of a patent may be deemed a disclosure ‘by another’ and thus included in the prior art.” Serono argued that so long as the relevant disclosure in the reference reflected the work of at least a subset of inventors on the challenged patent, it should not qualify as work “by another.” Rather, it reflected the work of the inventors of the challenged patent. Hopewell, on the other hand, argued that a prior disclosure may only be excluded from the prior art when there is complete identity between the inventors of the disclosure and the inventors named on the challenged patent.

In affirming the PTAB, the Federal Circuit largely adopted Hopewell’s argument. According to the court, for a reference to not be “by another,” and thus not qualify as prior art, the disclosure in the reference must reflect the work of the entire inventive entity of the challenged patent claim. When the challenged claim is the work of joint inventors, the disclosure in the reference must reflect the work of the entire inventive entity of the challenged claim in order to avoid being considered a work “by another.” Overlap between those who contributed to the invention in the disclosure and the inventors on the challenged claim does not exclude a reference as prior art.

Based on the facts of this case the court held that Serono failed to show one of the named inventors on the challenged patent made a significant contribution to the information disclosed in the asserted reference. Thus, that inventor could not be considered a joint inventor of the disclosure, and as a result, the disclosure must be deemed to be part of the prior art as having been made “by another.”

Practice Tip: When preparing or defending patents, especially in collaborative research environments, it is important to carefully document the inventive contributions of each named inventor to be able to show that the inventors of a patent claim are identical to the inventors that disclosed the invention in related publications. This can be critical in later proceedings where the status of prior art may hinge on the degree of overlap between the named inventors and the authors or inventors of a related publication.

Share This Insight

Previous Entries

IP Newsflash

November 3, 2025

The Federal Circuit recently clarified the requirement for work disclosed in a reference to qualify as “by another” under pre-AIA Sections 102(a) and (e), holding that there must be complete inventive identity between the information disclosed in the asserted reference and the inventors named on the relevant patent. 

...

Read More

IP Newsflash

October 31, 2025

The District Court for the Northern District of California recently granted a defendant’s motion to bifurcate, ordering that issues related to PGR estoppel should be decided in a bench trial, while the remaining issues in the case should proceed to a jury trial.

...

Read More

IP Newsflash

October 31, 2025

The Northern District of Iowa recently held that a defendant’s motion for partial summary judgment of invalidity was barred after the PTAB issued final written decisions, regardless of when the motion was filed. The defendant filed its motion before the final written decisions were issued, but the court rejected the defendant’s argument that the timing of the motion insulated it from estoppel.

...

Read More

IP Newsflash

October 1, 2025

In a recent final written decision, the PTAB determined that a reference patent was not prior art, despite the petitioner’s post‑filing attempt to correct its petition. While the petitioner argued that it intended to rely on the patent application’s earlier date of publication, both the corrected petition and the expert declaration continued to reference the issued patent rather than the published application.

...

Read More

IP Newsflash

September 30, 2025

The USPTO Director recently granted a petitioner’s request for rehearing of the decision discretionarily denying institution of inter partes review, ultimately vacating the original decision, and referring the petition to the board for an institution decision.

...

Read More

IP Newsflash

September 25, 2025

In considering claims to a method of reducing cardiovascular events, the Federal Circuit held that the term a “clinically proven effective” amount did not render the claims patentable over the prior art. Specifically, the Federal Circuit held that the “clinically proven effective” amount, whether limiting or not, could not be used to distinguish the prior art because the claims also specified the exact amount of the drugs to be administered in the method. The Federal Circuit also rejected patentee’s evidence of unexpected results because that evidence was tied solely to the “clinically proven effective” limitation.

...

Read More

IP Newsflash

September 24, 2025

The Federal Circuit reversed a district court’s denial of judgment as a matter of law on non-infringement, thereby setting aside a $106 million jury verdict, after holding that prosecution history estoppel barred the patentee from asserting infringement under the doctrine of equivalents.

...

Read More

IP Newsflash

September 17, 2025

A magistrate judge in the District of Delaware issued a Report and Recommendation, that found the sole asserted claim was a “single means” claim and therefore invalid for lack of enablement. In reaching that conclusion, the magistrate judge rejected the patentee’s argument that the preamble of the claim disclosed a second element that satisfied the combination requirement of Section 112, paragraph 6 because the preamble simply recited a descriptor of the very apparatus that was the subject of the means-plus-function limitation in the body of the claim. The district court judge presiding over this case has scheduled a hearing to review the magistrate’s ruling.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.